Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:23 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital, LLC | 9,342 0.200% | -223,508 (-95.99%) | Filing History |
| 2021-02-12 5:19 pm Sale | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | EcoR1 Capital, LLC | 76,628 2.100% | -153,257 (-66.67%) | Filing History |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital, LLC | 365,008 5.400% | 132,744 (+57.15%) | Filing History |
| 2021-02-12 4:06 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital, LLC | 0 0.000% | -2,248,306 (Position Closed) | Filing History |
| 2021-02-12 3:58 pm Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | EcoR1 Capital, LLC | 0 0.000% | -2,536,156 (Position Closed) | Filing History |
| 2021-02-12 3:52 pm Sale | 2020-12-31 | 13G | Merus N.V. MRUS | EcoR1 Capital, LLC | 0 0.000% | -1,906,861 (Position Closed) | Filing History |
| 2021-02-12 3:42 pm Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | EcoR1 Capital, LLC | 0 0.000% | -29,098 (Position Closed) | Filing History |
| 2021-02-12 3:36 pm Sale | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | EcoR1 Capital, LLC | 0 0.000% | -3,627,597 (Position Closed) | Filing History |
| 2021-02-12 3:27 pm Unchanged | 2020-12-31 | 13G | Chiasma, Inc. CHMA | EcoR1 Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 3:18 pm Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | EcoR1 Capital, LLC | 1,509,812 3.500% | -577,500 (-27.67%) | Filing History |
| 2021-01-26 12:21 pm Purchase | 2021-01-22 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | EcoR1 Capital, LLC | 4,368,500 6.800% | 4,368,500 (New Position) | Filing History |
| 2021-01-22 4:27 pm Purchase | 2021-01-12 | 13G | AC Immune S.A. ACIU | EcoR1 Capital, LLC | 4,702,160 6.600% | 4,702,160 (New Position) | Filing History |